0001420108-26-000004.txt : 20261006 0001420108-26-000004.hdr.sgml : 20261006 20261006144843 ACCESSION NUMBER: 0001420108-26-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20261006 DATE AS OF CHANGE: 20261006 EFFECTIVENESS DATE: 20261006 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Glucose Health, Inc. CENTRAL INDEX KEY: 0001420108 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences EIN: 901117742 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-600098 FILM NUMBER: 261443586 BUSINESS ADDRESS: STREET 1: 609 SW 8TH STREET, SUITE 600 CITY: BENTONVILLE STATE: AR ZIP: 72712 BUSINESS PHONE: 479-802-3827 MAIL ADDRESS: STREET 1: 609 SW 8TH STREET, SUITE 600 CITY: BENTONVILLE STATE: AR ZIP: 72712 FORMER COMPANY: FORMER CONFORMED NAME: Bio-Solutions Corp. DATE OF NAME CHANGE: 20071203 D 1 primary_doc.xml X0708 D LIVE 0001420108 Glucose Health, Inc. 609 SW 8TH STREET, SUITE 600 BENTONVILLE AR ARKANSAS 72712 479-802-3827 DELAWARE Bio-Solutions Corp. Corporation true John Duffy 609 SW 8th Street Suite 600 Bentonville AR ARKANSAS 72717 Executive Officer Director Mark Schaftlein 609 SW 8th Street Suite 600 Bentonville AR ARKANSAS 72717 Director Edmund Burke 609 SW 8th Street Suite 600 Bentonville AR ARKANSAS 72717 Director Christopher Jemapete 609 SW 8th Street Suite 600 Bentonville AR ARKANSAS 72717 Director Marc Hatch 609 SW 8th Street Suite 600 Bentonville AR ARKANSAS 72717 Executive Officer Other Health Care $1 - $1,000,000 06b false 2026-08-07 false true false 0 12000 12000 0 Amount represents value of restricted shares issued for services rendered by recipient to Issuer false 1 0 0 12000 true Amount equals value of restricted stock issued to entity owned by director for services rendered to the Issuer false Glucose Health, Inc. /s/ John Duffy John Duffy CEO 2026-10-06